Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Journal of Anesthesia
Erschienen in: Journal of Anesthesia 4/2013

01.08.2013 | Review Article

Anesthetic considerations in pediatric mastocytosis: a review

verfasst von: Norma J. Klein, Shad Misseldine

Erschienen in: Journal of Anesthesia | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

Mastocytosis is an orphan disease rarely encountered by practicing anesthesiologists. Children with mastocytosis often present for procedures or surgery requiring anesthesia. Because many of the medications commonly used in pediatric anesthesia have been reported to initiate mast cell activation, parents are often very anxious about their child’s perioperative experience. Laboratory investigations of serum histamine assays associated with different anesthetic drugs have not been shown to predict mast cell degranulation in these patients. However, the pediatric literature suggests that children with disease limited to the skin rarely suffer serious side effects from anesthesia, and there are no reported fatalities. Preoperative prophylaxis is usually based on expert opinion and case reports. Detailed tables summarizing reports of anesthetic medications used for children with mastocytosis undergoing anesthesia, reported side effects, and suggested prophylaxis regimens are included in this review.
Literatur
1.
Castells M, Metcalfe DD, Escribano L. Diagnosis and treatment of cutaneous mastocytosis in children: practical recommendations. Am J Clin Dermatol. 2011;12:259–70.PubMedCrossRef
2.
Hermine O, Lortholary O, Leventhal PS, Catteau A, Soppelsa F, Baude C, Cohen-Akenine A, Palmerini F, Hanssens K, Yang Y, Sobol H, Fraytag S, Ghez D, Suarez F, Barete S, Casassus P, Sans B, Arock M, Kinet JP, Dubreuil P, Moussy A. Case-control cohort study of patients’ perceptions of disability in mastocytosis. PLoS ONE. 2008;3:e2266.PubMedCrossRef
3.
Greenblatt EP, Chen L. Urticaria pigmentosa: an anesthetic challenge. J Clin Anesth. 1990;2:108–15.PubMedCrossRef
4.
Carter MC, Uzzaman A, Scott LM, Metcalfe DD, Quezado Z. Pediatric mastocytosis: routine anesthetic management for a complex disease. Anesth Analg. 2008;107:422–7.PubMedCrossRef
5.
Shaffer HC, Parsons DJ, Peden DB, Morrell D. Recurrent syncope and anaphylaxis as presentation of systemic mastocytosis in a pediatric patient: case report and literature review. J Am Acad Dermatol. 2006;54:S210–3.PubMedCrossRef
6.
Delalande JP, Rea D, Fenoll B. Absence of mast cell degranulation during general anesthesia in a child with mastocytosis. Ann Fr Anesth Reanim. 1992;11:393–4.PubMed
7.
Heib V, Becker M, Taube C, Stassen M. Advances in the understanding of mast cell function. Br J Haematol. 2008;142:683–94.PubMedCrossRef
8.
Nunez-Lopez R, Escribano L, Schernthaner GH, Prados A, Rodriguez-Gonzalez R, Diaz-Agustin B, Lopez A, Hauswirth A, Valent P, Almeida J, Bravo P, Orfao A. Overexpression of complement receptors and related antigens on the surface of bone marrow mast cells in patients with systemic mastocytosis. Br J Haematol. 2003;120:257–65.PubMedCrossRef
9.
Sick E, Niederhoffer N, Takeda K, Landry Y, Gies JP. Activation of CD47 receptors causes histamine secretion from mast cells. Cell Mol Life Sci. 2009;66:1271–82.PubMedCrossRef
10.
Valent P, Akin C, Arock M, Brockow K, Butterfield JH, Carter MC, Castells M, Escribano L, Hartmann K, Lieberman P, Nedoszytko B, Orfao A, Schwartz LB, Sotlar K, Sperr WR, Triggiani M, Valenta R, Horny HP, Metcalfe DD. Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal. Int Arch Allergy Immunol. 2012;157:215–25.PubMedCrossRef
11.
Ferry X, Brehin S, Kamel R, Landry Y. G protein-dependent activation of mast cell by peptides and basic secretagogues. Peptides. 2002;23:1507–15.PubMedCrossRef
12.
Valent P, Akin C, Escribano L, Fodinger M, Hartmann K, Brockow K, Castells M, Sperr WR, Kluin-Nelemans HC, Hamdy NA, Lortholary O, Robyn J, van Doormaal J, Sotlar K, Hauswirth AW, Arock M, Hermine O, Hellmann A, Triggiani M, Niedoszytko M, Schwartz LB, Orfao A, Horny HP, Metcalfe DD. Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria. Eur J Clin Invest. 2007;37:435–53.PubMedCrossRef
13.
14.
Middelkamp Hup MA, Heide R, Tank B, Mulder PG, Oranje AP. Comparison of mastocytosis with onset in children and adults. J Eur Acad Dermatol Venereol. 2002;16:115–20.PubMedCrossRef
15.
16.
Gonzalez de Olano D, de la Hoz Caballer B, Nunez Lopez R, Sanchez Munoz L, Cuevas Agustin M, Dieguez MC, Alvarez Twose I, Castells MC, Escribano Mora L. Prevalence of allergy and anaphylactic symptoms in 210 adult and pediatric patients with mastocytosis in Spain: a study of the Spanish network on mastocytosis (REMA). Clin Exp Allergy. 2007;37:1547–55.
17.
Ben-Amitai D, Metzker A, Cohen HA. Pediatric cutaneous mastocytosis: a review of 180 patients. Isr Med Assoc J. 2005;7:320–2.PubMed
18.
Akin C, Metcalfe DD. Surrogate markers of disease in mastocytosis. Int Arch Allergy Immunol. 2002;127:133–6.PubMedCrossRef
19.
Hannaford R, Rogers M. Presentation of cutaneous mastocytosis in 173 children. Australas J Dermatol. 2001;42:15–21.PubMedCrossRef
20.
Castells M, Austen KF. Mastocytosis: mediator-related signs and symptoms. Int Arch Allergy Immunol. 2002;127:147–52.PubMedCrossRef
21.
Villeneuve V, Kaufman I, Weeks S, Deschamps A. Anesthetic management of a labouring parturient with urticaria pigmentosa. Can J Anaesth. 2006;53:380–4.PubMedCrossRef
22.
Pehlivanidis C, Fotoulaki M, Boucher W, Kempuraj D, Pang X, Konstantinidou A, Theoharides TC. Acute stress-induced seizures and loss of consciousness in a ten-year-old boy with cutaneous mastocytosis. J Clin Psychopharmacol. 2002;22:221–4.PubMedCrossRef
23.
Damodar S, John CN, Gopalakrishnan G, Nair S, Samuel R, Thomas M, Shetty DP. Mast cell disease: surgical and anesthetic implications. J Pediatr Hematol Oncol. 2006;28:446–9.PubMedCrossRef
24.
Theoharides TC. Autism spectrum disorders and mastocytosis. Int J Immunopathol Pharmacol. 2009;22:859–65.PubMed
25.
Bodemer C, Hermine O, Palmerini F, Yang Y, Grandpeix-Guyodo C, Leventhal PS, Hadj-Rabia S, Nasca L, Georgin-Lavialle S, Cohen-Akenine A, Launay JM, Barete S, Feger F, Arock M, Catteau B, Sans B, Stalder JF, Skowron F, Thomas L, Lorette G, Plantin P, Bordigoni P, Lortholary O, de Prost Y, Moussy A, Sobol H, Dubreuil P. Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations. J Invest Dermatol. 2010;130:804–15.PubMedCrossRef
26.
Heide R, Beishuizen A, De Groot H, Den Hollander JC, Van Doormaal JJ, De Monchy JG, Pasmans SG, Van Gysel D, Oranje AP. Mastocytosis in children: a protocol for management. Pediatr Dermatol. 2008;25:493–500.PubMedCrossRef
27.
Ahmad N, Evans P, Lloyd-Thomas AR. Anesthesia in children with mastocytosis—a case based review. Paediatr Anaesth. 2009;19:97–107.PubMedCrossRef
28.
Horny HP, Sotlar K, Valent P. Mastocytosis: state of the art. Pathobiology. 2007;74:121–32.PubMedCrossRef
29.
Castells M. Mast cell mediators in allergic inflammation and mastocytosis. Immunol Allergy Clin North Am. 2006;26:465–85.PubMedCrossRef
30.
Pettigrew HD, Teuber SS, Kong JS, Gershwin ME. Contemporary challenges in mastocytosis. Clin Rev Allergy Immunol. 2010;38:125–34.PubMedCrossRef
31.
Heide R, Zuidema E, Beishuizen A, Den Hollander JC, Van Gysel D, Seyger MM, Pasmans SG, Kakourou T, Oranje AP. Clinical aspects of diffuse cutaneous mastocytosis in children: two variants. Dermatology. 2009;219:309–15.PubMedCrossRef
32.
Buttner C, Henz BM, Welker P, Sepp NT, Grabbe J. Identification of activating c-kit mutations in adult-, but not in childhood-onset indolent mastocytosis: a possible explanation for divergent clinical behavior. J Invest Dermatol. 1998;111:1227–31.PubMedCrossRef
33.
Longley BJ Jr, Morganroth GS, Tyrrell L, Ding TG, Anderson DM, Williams DE, Halaban R. Altered metabolism of mast-cell growth factor (c-kit ligand) in cutaneous mastocytosis. N Engl J Med. 1993;328:1302–7.PubMedCrossRef
34.
Brockow K, Akin C, Huber M, Metcalfe DD. IL-6 levels predict disease variant and extent of organ involvement in patients with mastocytosis. Clin Immunol. 2005;115:216–23.PubMedCrossRef
35.
Greenhawt M, Akin C. Mastocytosis and allergy. Curr Opin Allergy Clin Immunol. 2007;7:387–92.PubMedCrossRef
36.
Siegert SI, Diebold J, Ludolph-Hauser D, Lohrs U. Are gastrointestinal mucosal mast cells increased in patients with systemic mastocytosis? Am J Clin Pathol. 2004;122:560–5.PubMedCrossRef
37.
Gotlib J. On being metachromatic: mystique and misunderstanding in mastocytosis. Am J Hematol. 2009;84:779–81.PubMedCrossRef
38.
Proelss J, Wenzel J, Ko Y, Bieber T, Bauer R. Tryptase detection in bone-marrow blood: a new diagnostic tool in systemic mastocytosis. J Am Acad Dermatol. 2007;56:453–7.PubMedCrossRef
39.
Schwartz LB. Diagnostic value of tryptase in anaphylaxis and mastocytosis. Immunol Allergy Clin North Am. 2006;26:451–63.PubMedCrossRef
40.
Valent P, Akin C, Sperr WR, Mayerhofer M, Fodinger M, Fritsche-Polanz R, Sotlar K, Escribano L, Arock M, Horny HP, Metcalfe DD. Mastocytosis: pathology, genetics, and current options for therapy. Leuk Lymphoma. 2005;46:35–48.PubMedCrossRef
41.
Vaughan ST, Jones GN. Systemic mastocytosis presenting as profound cardiovascular collapse during anaesthesia. Anaesthesia. 1998;53:804–7.PubMedCrossRef
42.
Desborough JP, Taylor I, Hattersley A, Garden A, Wolff A, Bloom SR, Morgan M. Massive histamine release in a patient with systemic mastocytosis. Br J Anaesth. 1990;65:833–6.PubMedCrossRef
43.
Roberts LJ 2nd. Recurrent syncope due to systemic mastocytosis. Hypertension. 1984;6:285–94.PubMed
44.
Florian S, Krauth MT, Simonitsch-Klupp I, Sperr WR, Fritsche-Polanz R, Sonneck K, Fodinger M, Agis H, Bohm A, Wimazal F, Horny HP, Valent P. Indolent systemic mastocytosis with elevated serum tryptase, absence of skin lesions, and recurrent severe anaphylactoid episodes. Int Arch Allergy Immunol. 2005;136:273–80.PubMedCrossRef
45.
Tirel O, Chaumont A, Ecoffey C. Circulatory arrest in the course of anesthesia for a child with mastocytosis. Ann Fr Anesth Reanim. 2001;20:874–5.PubMedCrossRef
46.
Goldfinger MM, Sandadi J. Undiagnosed systemic mastocytosis in a teenager revealed during general anesthesia. Paediatr Anaesth. 2010;20:290–1.PubMedCrossRef
47.
Ahmad N, Evans P. Re: undiagnosed systemic mastocytosis in a teenager revealed during general anesthesia. Paediatr Anaesth. 2010;20:781–2.PubMedCrossRef
48.
Marone G, Stellato C, Mastronardi P, Mazzarella B. Mechanisms of activation of human mast cells and basophils by general anesthetic drugs. Ann Fr Anesth Reanim. 1993;12:116–25.PubMedCrossRef
49.
Mertes PM, Tajima K, Regnier-Kimmoun MA, Lambert M, Iohom G, Gueant-Rodriguez RM, Malinovsky JM. Perioperative anaphylaxis. Med Clin North Am. 2010;94:761–89, xi.
50.
Laxenaire MC, Mertes PM. Anaphylaxis during anaesthesia. Results of a two-year survey in France. Br J Anaesth. 2001;87:549–58.PubMedCrossRef
51.
Brockow K, Jofer C, Behrendt H, Ring J. Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients. Allergy. 2008;63:226–32.PubMedCrossRef
52.
Lerno G, Slaats G, Coenen E, Herregods L, Rolly G. Anaesthetic management of systemic mastocytosis. Br J Anaesth. 1990;65:254–7.PubMedCrossRef
53.
Philbin DM, Moss J, Akins CW, Rosow CE, Kono K, Schneider RC, VerLee TR, Savarese JJ. The use of H1 and H2 histamine antagonists with morphine anesthesia: a double-blind study. Anesthesiology. 1981;55:292–6.PubMedCrossRef
54.
Worobec AS, Metcalfe DD. Mastocytosis: current treatment concepts. Int Arch Allergy Immunol. 2002;127:153–5.PubMedCrossRef
55.
Chaar CI, Bell RL, Duffy TP, Duffy AJ. Guidelines for safe surgery in patients with systemic mastocytosis. Am Surg. 2009;75:74–80.PubMed
56.
Vanin E, Zanconato S, Baraldi E, Marcazzo L. Anaphylactic reaction after skin-prick testing in an 8-year-old boy. Pediatr Allergy Immunol. 2002;13:227–8.PubMedCrossRef
57.
Kirshenbaum AS, Kettelhut BV, Metcalfe DD, Garriga MM. Mastocytosis in infants and children: recognition of patterns of skin disease. Allergy Proc. 1989;10:17–21.PubMedCrossRef
58.
Rosow CE, Philbin DM, Keegan CR, Moss J. Hemodynamics and histamine release during induction with sufentanil or fentanyl. Anesthesiology. 1984;60:489–91.PubMedCrossRef
59.
Moss J, Rosow CE. Histamine release by narcotics and muscle relaxants in humans. Anesthesiology. 1983;59:330–9.PubMedCrossRef
60.
Flacke JW, Flacke WE, Bloor BC, Van Etten AP, Kripke BJ. Histamine release by four narcotics: a double-blind study in humans. Anesth Analg. 1987;66:723–30.PubMedCrossRef
61.
Sebel PS, Hoke JF, Westmoreland C, Hug CC Jr, Muir KT, Szlam F. Histamine concentrations and hemodynamic responses after remifentanil. Anesth Analg. 1995;80:990–3.PubMed
62.
Blunk JA, Schmelz M, Zeck S, Skov P, Likar R, Koppert W. Opioid-induced mast cell activation and vascular responses is not mediated by mu-opioid receptors: an in vivo microdialysis study in human skin. Anesth Analg. 2004;98:364–70 (table of contents).
63.
Naguib M, Samarkandi AH, Bakhamees HS, Magboul MA. el-Bakry AK. Histamine-release haemodynamic changes produced by rocuronium, vecuronium, mivacurium, atracurium and tubocurarine. Br J Anaesth. 1995;75:588–92.PubMedCrossRef
64.
Selcuk M, Celebioglu B, Celiker V, Basgul E, Aypar U. Infusion and bolus administration of cisatracurium—effects on histamine release. Middle East J Anesthesiol. 2005;18:407–19.PubMed
65.
Koppert W, Blunk JA, Petersen LJ, Skov P, Rentsch K, Schmelz M. Different patterns of mast cell activation by muscle relaxants in human skin. Anesthesiology. 2001;95:659–67.PubMedCrossRef
66.
Stellato C, de Paulis A, Cirillo R, Mastronardi P, Mazzarella B, Marone G. Heterogeneity of human mast cells and basophils in response to muscle relaxants. Anesthesiology. 1991;74:1078–86.PubMedCrossRef
67.
Doenicke AW, Czeslick E, Moss J, Hoernecke R. Onset time, endotracheal intubating conditions, and plasma histamine after cisatracurium and vecuronium administration. Anesth Analg. 1998;87:434–8.PubMed
68.
Atkins PC, von Allmen C, Valenzano M, Olson R, Shalit M, Zweiman B. Determinants of in vivo histamine release in cutaneous allergic reactions in humans. J Allergy Clin Immunol. 1990;86:371–9.PubMedCrossRef
69.
Petersen LJ, Nielsen HJ, Skov PS. Codeine-induced histamine release in intact human skin monitored by skin microdialysis technique: comparison of intradermal injections with an atraumatic intraprobe drug delivery system. Clin Exp Allergy. 1995;25:1045–52.PubMedCrossRef
70.
Sutter MC, Beaulieu G, Birt AR. Histamine liberation by codeine and polymyxin B in urticaria pigmentosa. Arch Dermatol. 1962;86:217–21.PubMedCrossRef
71.
Levy JH, Davis GK, Duggan J, Szlam F. Determination of the hemodynamics and histamine release of rocuronium (Org 9426) when administered in increased doses under N2O/O2-sufentanil anesthesia. Anesth Analg. 1994;78:318–21.PubMedCrossRef
72.
Cannon JE, Fahey MR, Moss J, Miller RD. Large doses of vecuronium and plasma histamine concentrations. Can J Anaesth. 1988;35:350–3.PubMedCrossRef
73.
Tullock WC, Diana P, Cook DR, Wilks DH, Brandom BW, Stiller RL, Beach CA. Neuromuscular and cardiovascular effects of high-dose vecuronium. Anesth Analg. 1990;70:86–90.PubMedCrossRef
74.
Kimura K, Adachi M, Kubo K. Histamine release during the induction of anesthesia with propofol in allergic patients: a comparison with the induction of anesthesia using midazolam-ketamine. Inflamm Res. 1999;48:582–7.PubMedCrossRef
75.
Konrad FM, Schroeder TH. Anaesthesia in patients with mastocytosis. Acta Anaesthesiol Scand. 2009;53:270–1.PubMedCrossRef
76.
Laxenaire MC, Borgo J, Menu N, Holzer J, Royer R. Evolution of plasma histamine after midazolam in patients at risk of histamine liberation. Ann Fr Anesth Reanim. 1985;4:238–40.PubMedCrossRef
77.
Kimura K, Adachi M, Kubo K, Ikemoto Y. Incidence of histamine release after the administration of midazolam-ketamine in allergic patients. Fukuoka igaku zasshi = Hukuoka Acta Medica. 1999;90:448–56.PubMed
78.
Tas PW, Stossel C, Roewer N. Inhibition of the histamine-induced Ca2+ influx in primary human endothelial cells (HUVEC) by volatile anaesthetics. Eur J Anaesthesiol. 2008;25:976–85.PubMedCrossRef
79.
Lahat A, Ben-Horin S, Lang A, Fudim E, Picard O, Chowers Y. Lidocaine down-regulates nuclear factor-kappaB signalling and inhibits cytokine production and T cell proliferation. Clin Exp Immunol. 2008;152:320–7.PubMedCrossRef
80.
Yanagi H, Sankawa H, Saito H, Iikura Y. Effect of lidocaine on histamine release and Ca2 + mobilization from mast cells and basophils. Acta Anaesthesiol Scand. 1996;40:1138–44.PubMedCrossRef
81.
Rosenbaum KJ, Strobel GE. Anesthetic considerations in mastocytosis. Anesthesiology. 1973;38:398–401.PubMedCrossRef
82.
Coulson J, Thompson JP. Paracetamol (acetaminophen) attenuates in vitro mast cell and peripheral blood mononucleocyte cell histamine release induced by N-acetylcysteine. Clin Toxicol (Phila). 2010;48:111–4.PubMedCrossRef
83.
Brodier C, Guyot E, Palot M, David P, Rendoing J. Anesthesia of a child with a cutaneous mastocytosis. Can Anesthesiol. 1993;41:77–9.
84.
Coleman MA, Liberthson RR, Crone RK, Levine FH. General anesthesia in a child with urticaria pigmentosa. Anesth Analg. 1980;59:704–6.PubMedCrossRef
85.
James PD, Krafchik BR, Johnston AE. Cutaneous mastocytosis in children: anaesthetic considerations. Can J Anaesth. 1987;34:522–4.PubMedCrossRef
86.
Escribano L, Akin C, Castells M, Orfao A, Metcalfe DD. Mastocytosis: current concepts in diagnosis and treatment. Ann Hematol. 2002;81:677–90.PubMedCrossRef
87.
Kootte AM, Haak A, Roberts LJ. The flush syndrome: an expression of systemic mastocytosis with increased prostaglandin D2 production. Neth J Med. 1983;26:18–20.PubMed
88.
Macksey LF, White B. Anesthetic management in a pediatric patient with Noonan syndrome, mastocytosis, and von Willebrand disease: a case report. AANA J. 2007;75:261–4.PubMed
89.
Iqbal A, Morton C, Kong KL. Fibrinolysis during anaphylaxis, and its spontaneous resolution, as demonstrated by thromboelastography. Br J Anaesth. 2010;105:168–71.PubMedCrossRef
90.
Koenig M, Morel J, Reynaud J, Varvat C, Cathebras P. An unusual cause of spontaneous bleeding in the intensive care unit—mastocytosis: a case report. Cases J. 2008;1:100.PubMedCrossRef
91.
Fisher MM, Baldo BA. Mast cell tryptase in anaesthetic anaphylactoid reactions. Br J Anaesth. 1998;80:26–9.PubMedCrossRef
92.
Nelson LP, Savelli-Castillo I. Dental management of a pediatric patient with mastocytosis: a case report. Pediatr Dent. 2002;24:343–6.PubMed
93.
Roy J, Metry DW, Hicks J, Morgan AJ, Heptulla RA. An unusual presentation of mastocytosis: unilateral swelling of the vulva. Pediatr Dermatol. 2005;22:554–7.PubMedCrossRef
94.
Cainelli T, Marchesi L, Pasquali F, Rozzoni M. Monozygotic twins discordant for cutaneous mastocytosis. Arch Dermatol. 1983;119:1021–2.PubMedCrossRef
95.
Lappe U, Aumann V, Mittler U, Gollnick H. Familial urticaria pigmentosa associated with thrombocytosis as the initial symptom of systemic mastocytosis and Down’s syndrome. J Eur Acad Dermatol Venereol. 2003;17:718–22.PubMedCrossRef
96.
Metadaten
Titel
Anesthetic considerations in pediatric mastocytosis: a review
verfasst von
Norma J. Klein
Shad Misseldine
Publikationsdatum
01.08.2013
Verlag
Springer Japan
Erschienen in
Journal of Anesthesia / Ausgabe 4/2013
Print ISSN: 0913-8668
Elektronische ISSN: 1438-8359
DOI
https://doi.org/10.1007/s00540-013-1563-2

Weitere Artikel der Ausgabe 4/2013

Journal of Anesthesia 4/2013 Zur Ausgabe

Original Article

The effects of anesthetic technique and ambient temperature on thermoregulation in lower extremity surgery

Letter to the Editor

Use of microaggregate blood filters instead of leukocyte reduction filters to purify salvaged, autologous blood for re-transfusion during obstetric surgery

Review Article

QT interval abnormalities: risk factors and perioperative management in long QT syndromes and Torsades de Pointes

Letter to the Editor

Evaluation of retrograde intubation in patients with limited mouth opening

Original Article

A novel method for SLIPA™ size selection, for adult patients, on the basis of chamber length

Letter to the Editor

Misdiagnosis of an early postoperative upper limb deficit

Neu im Fachgebiet AINS

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Häufigste Gründe für Brustschmerzen bei Kindern

06.05.2024 Pädiatrische Diagnostik Nachrichten

Akute Brustschmerzen sind ein Alarmsymptom par exellence, schließlich sind manche Auslöser lebensbedrohlich. Auch Kinder klagen oft über Schmerzen in der Brust. Ein Studienteam ist den Ursachen nachgegangen.

Aquatherapie bei Fibromyalgie wirksamer als Trockenübungen

03.05.2024 Fibromyalgiesyndrom Nachrichten

Bewegungs-, Dehnungs- und Entspannungsübungen im Wasser lindern die Beschwerden von Patientinnen mit Fibromyalgie besser als das Üben auf trockenem Land. Das geht aus einer spanisch-brasilianischen Vergleichsstudie hervor.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren
Bildnachweise